Anna A. Ilyina

Anna A. Ilyina

Auto-generated profile, based on publicly available information

Anna A. Ilyina

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
MVMaria Dmitrievna Varyukhina
Maria Dmitrievna Varyukhina
AVAlexey N. Vorobyev
Alexey N. Vorobyev
DLDmirty V. Levin
Dmirty V. Levin
AIAnna A. Ilyina
Anna A. Ilyina
DKDmitry L. Kolesov
Dmitry L. Kolesov
ЯАЯковлев Алексей Александрович
Яковлев Алексей Александрович
Background: Postoperative skull bone defects are one of the urgent problems of neurorehabilitation. Skull bone defect limits the scope of rehabilitation measures, complicates patient care, and leads to secondary complications. Significant risks of postop complications demands making a decision about surgery individually. Surgery timing varies widely and remains controversal. Aims: to formulate the features of skull bone defects reconstruction in patients at various stages of rehabilitation based on the analysis of the frequency and structure of postoperative surgical complications. Materials and methods: The retrospective analysis of cranioplasty results was performed in the 129 patients treated in Federal Scientific and Clinical Center of Intensive Care Medicine and Rehabilitology from 2018 to 2022 at various stages of rehabilitation (intensive care, inpatient, outpatient). The features of surgery, frequency and structure of surgical complications dependent on rehabilitation stage were analyzed. Results: A total of 129 patients were included in the study: 84 men (65%) and 45 women (35%). The average age of the patients was 43.213.9 years. The average timing of cranioplasty surgery was 79 days [IQR 60; 133]. Seventy two patients (56%) were operated on at the intensive care stage of rehabilitation, forty (31%) and seventeen (13%) patients were operated on at the inpatient and outpatient stages, respectively. In total, complications occurred in 16 patients (12%). Intensive care patients required careful preoperative preparation, correction of homeostasis and metabolism disorders. In our series, postoperative complications were observed in 12 patients on intensive care stage (17%); all cases of hydrocephalus occurred only in intensive care patients. In patients operated on at the inpatient stage of rehabilitation, complications occurred in 4 cases (10%), while there was no statistically significant difference in the incidence of complications in patients from the intensive care and inpatient subgroups (p=0.334). Complications in patients at the outpatient stage of rehabilitation were not observed in our series. Conclusions: Cranioplasty surgery is possible even in somatically burdened patients at the intensive care stage of rehabilitation. It allows to expand the scope of rehabilitation measures and facilitate medical care. When planning surgical intervention in the early stages after the cranioplasty surgery, it is important to take into account the increased risk of hydrocephalus manifestation.

29 December 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
AIA. A. Ilyina
A. A. Ilyina
MPM. V. Petrova
M. V. Petrova
DID. V. Ilyin
D. V. Ilyin
AGAndrey Grechko
Andrey Grechko
VGV. V. Gudozhnikova
V. V. Gudozhnikova
Introduction. The article focuses on exploring the possibilities of intermittent hypoxia-hyperoxia therapy (IHHT) as an effective and safe method for neurorehabilitation of patients who have suffered severe brain injuries and remain in a state of chronic critical illness. Literature review of scientific publications indicates that IHHT can activate important adaptive mechanisms, modulate antioxidant pathways, improve mitochondrial function, and stimulate neuroplasticity. The objective was to review current data on the mechanisms of intermittent hypoxia-hyperoxia therapy and evaluate its potential as a treatment and rehabilitation strategy for patients with chronic critical illness following severe cerebrovascular events in neurological intensive care units. Materials and Methods. We conducted a literature review using databases such as Web of Science, Scopus, PubMed, RSCI, and eLibrary. The analysis included 43 sources presenting up-to-date clinical and experimental approaches to the use of IHHT, its underlying mechanisms, and efficacy assessment. In addition, the article also includes the authors’ ICU experience with IHHT in chronically critically ill patients following severe cerebral catastrophes. Results. IHHT has been shown to activate several key adaptive mechanisms, including the expression of HIF-1α (Hypoxia-inducible factor 1-alpha) and HIF-2α (Hypoxia-inducible factor 2-alpha), modulation of antioxidant pathways involving Nrf2 (Nuclear factor erythroid 2-related factor 2), improvement of mitochondrial function, stimulation of angiogenesis and neuroplasticity. Positive clinical effects are observed when therapy parameters are carefully individualized and safety is closely monitored. The method shows promising potential for integration into personalized therapeutic and rehabilitation protocols in intensive care settings. Conclusion. Intermittent hypoxia-hyperoxia therapy represents a promising adjunctive approach for ICU patients with sequelae of severe cerebral catastrophes, enhancing endogenous recovery mechanisms. In the future, multicenter clinical studies are required to standardize the method, refine indications and contraindications, and develop clinical protocols for its use in intensive care.

29 June 2025 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
AIAnna A. Ilyina
Anna A. Ilyina
MPMarina V. Petrova
Marina V. Petrova
AGAndrey Grechko
Andrey Grechko
DIDmitry V. Ilyin
Dmitry V. Ilyin
GSGalina K. Spirina
Galina K. Spirina
ИВИльин Дмитрий Владиленович
Ильин Дмитрий Владиленович
The term “chronic critical illness” was first coined in 1985 by researchers at Stanford University School of Medicine in an article with the provocative headline “Save or let die?” The authors described a unique category of patients that stood out among the general population of patients in intensive care units. These patients, who received a full range of intensive care, did not die, but also did not achieve recovery for weeks, months, or even years after an acute Injury. This research opened doors for further study. National and foreign sources show that patients with chronic critical illness comprise 5–20% of intensive care unit patients. Despite intensive treatment and rehabilitation measures, most of these patients eventually develop homeostasis disorders and complications, leading to multiple organ failure and death. This article presents an intermittent hypoxia-hyperoxia therapy case study for a patient with the chronic disorder of consciousness. The patient completed two weeks of intensive care therapy at the Scientific Research Institute of rehabilitation named after Prof. Pryanikova I.V. of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology. Metered-dose intermittent hypoxia-hyperoxia therapy training improved the patient’s adaptation and reduced neurological deficits as a part of comprehensive rehabilitation. Intermittent hypoxic-hyperoxia therapy shows potential in the intensive care unit patient treatment and in rehabilitation.

27 May 2022 in Clinical nutrition and metabolism
Verified
Journal Article
Open access
PDF file
MPMarina V. Petrova
Marina V. Petrova
ASAlexandr E. Shestopalov
Alexandr E. Shestopalov
AIAnna A. Ilina
Anna A. Ilina
AKArkady E. Kutsenko
Arkady E. Kutsenko
VMViktoriya V. Makarova
Viktoriya V. Makarova
КЭКуценко Аркадий Эдуардович
Куценко Аркадий Эдуардович
The Coronavirus Disease 2019 (COVID-19) pandemic, declared by the World Health Organization on March 11, 2020, has made significant adjustments to the principles of organizing medical care, including treatment, nutrition, and care of patients in infectious hospitals. The disease has different clinical courses: from mild asymptomatic to extremely severe, requiring aggressive medical interventions, such as organ replacement therapy to replace vital body functions. The spread of viral infection was global, but the pathophysiological aspects of the course of COVID-19 have not been studied comprehensively. The development of acute respiratory distress syndrome and systemic inflammatory response syndrome as part of the severe course of the disease is accompanied by severe metabolic disorders that require close attention. It is necessary to correct the clinical manifestations of organ dysfunction under severe hypercatabolism. Considerable importance is given to the peculiarities of providing nutritional support to patients using specialized nutritional mixtures to prevent conditions that worsen the prognosis of recovery and survival of patients. The target cells of the virus are angiotensin-converting enzyme receptors of the respiratory, nervous, urinary, and cardiovascular systems and organs of the gastrointestinal tract. Consequently, the site of the infection at different organs and systems gives rise to the phenomena of respiratory failure and several heterogeneous clinical manifestations of the disease, which can affect all ties in the pathogenesis of nutritional deficiency. Malnutrition is usually due to the mismatch between the intake and consumption of nutrients, micro- and macroelements. The causes for the imbalance of the intake-expenditure system can be divided into three groups: reduced nutrient intake, increased consumption due to hypercatabolism or hypermetabolism, and malabsorption and increased nutritional losses due to direct and indirect damages to the gastrointestinal tract. The division is traditional because, in the case of severe forms of coronavirus infection, there is always the presence of two or more factors leading to nutritional deficiencies. In this study, we systematized the ways in which we provide nutritional support based on the prevalent causes of protein-energy malnutrition, taking into account the patients individual needs and the extent of respiratory support. Several articles published by foreign colleagues and our own experience in the Department of Anesthesiology and Intensive Care for Patients with a New Coronavirus Infection COVID-19 at the Russian Academy of Sciences Central Clinical Hospital in Moscow in 2020 were analyzed. This study discusses in detail the problems and characteristics of clinical nutrition that a practicing intensive care specialist faces when enduring all possible measures to maintain the stable homeostasis of the patient.

9 December 2022 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
ABAleksandra V. Burmistrova
Aleksandra V. Burmistrova
AVAlexey N. Vorobyev
Alexey N. Vorobyev
MVMaria Dmitrievna Varyukhina
Maria Dmitrievna Varyukhina
AIAnna A. Ilina
Anna A. Ilina
MRMargarita L. Radutnaya
Margarita L. Radutnaya
ЯАЯковлев Алексей Александрович
Яковлев Алексей Александрович
BACKGROUND: Pain in cancer patients, often poorly treated, cause severe distress for patients and their caregivers, and significantly reduces quality of life. Modern guides for the medical treatment of chronic pain in cancer patients are not effective in all cases, especially when chronic neuropathic pain syndrome occurs. In this regard, there is a need for a multidisciplinary personalized approach to the tactics of chronic pain management in favor of surgical methods at earlier stages of this condition. Nowadays neuromodulation is widely used for the treatment of neuropathic chronic pain syndrome in patients with various pathologies, whereas it is not used routinely in cancer patients. CLINICAL CASE DESCRIPTION: We introduce a case report of successfully applied neuromodulation in patient with severe chronic pain syndrome due to rectal cancer. Epidural spinal cord stimulation at Th10Th12 levels allowed to stop the systemic use of opioids and achieve long-term remission. Spinal cord stimulation has shown itself to be very promising and significantly improved patients quality of life. CONCLUSIONS: Our case report evidently shows that current chronic pain management guides and treatment recommendations needs a revision and neuromodulation usage in category of cancer patients should be considered.